the good doctor on: Not all Macular Degenerations are Alike

Blog Vol. II.25, Not all Macular Degenerations are Alike.

In previous blogs I have discussed vision loss, a topic close to my heart. One of the biggest causes of vision loss in North America is macular degeneration. Back in the late ’80s, there were staggering projections for the incidence of macular degeneration with the aging population. That was one of the main reasons why I completed a one-year residency on Low Vision at Waterloo University, to help with the oncoming wave. Thankfully, new research and treatments reduced the number of people losing sight. Changes in behaviour like eliminating smoking, wearing UV protection, and taking antioxidants, as well as new treatments with Anti-VGEF injections, were critical in this trend. I still practiced low vision, but fortunately, with far fewer patients.

So now we can slow down the progress of “Dry” macular degeneration and we can stop the devastating effects of the “Wet” form of the disease, but there is one type that still has eluded us and continued to wreak havoc: the “Geographic” form. It is called geographic atrophy and it is a devastating form of macular degeneration. Changes in diet and behaviour do not seem to help this form of atrophy. Recently, details from research at the University of Virginia with Dr. Jayakrishna Ambati and his collaborators have found a possible help for this condition, which is so hopeful.

The atrophy is devastating because it continues to spread and affect a large area of the central retina (essential for sight), making visual aids such as magnifiers difficult if not impossible to use. Dr. Ambati discovered that the cells at the retinal level had a large buildup of a toxic substance called Alu DNA. It came as a surprise to him that this substance was being manufactured in the cell’s cytoplasm, unlike most DNA that is only made in the cell’s nucleus; this was not expected and may be the key, or a key, to finding an effective treatment. This high concentration of Alu DNA triggers harmful inflammation and eventual death of the cells, all bad.

The good news is that studies with HIV drugs showed a reduction in the development of existing dry macular degeneration by up to 40 %. A class of these HIV drugs, Kamuvudines, could block the harmful inflammation in geographic macular degeneration and protect against retinal cell death. Fantastic. He hopes that clinical trials with this drug start soon.

In the meantime, studies are showing a reduction in dry macular degeneration when taking high doses of omega 3 supplements. Could there be a possible tie-in with the inflammatory process in the retinal cells and the protection that these fatty acids can bring?

Let the trials begin,

Til Next Week,

the good doctor, Dr. Mark Germain, Burlington Optometrist




By Dr. Mark Germain May 1, 2026
The good doctor discusses how the eye is a window to the heart with the help of the OCT.
The good doctor take a deeper look at how gut health is connected to eye tissues.
By Dr. Mark Germain April 29, 2026
Blog vol 6.40. The Gut and the Eyes. One of my biggest jobs is to keep abreast of new research and advances in eye health. Most recently, we have seen new stem cell research, gene therapies, as well as new drugs for dry and wet macular degeneration. In January of this year, there was an article in the journal, Cell Death and Disease, that looked at cell apoptosis, specifically with the photoreceptors of the eye. (Read the article here ). Apoptosis is the genetic programming of deliberate and constructive cell death, allowing for the maintenance of healthy structures and systems in the body. Some estimates have the body replacing 50 to 70 billion cells daily by this process. Necrosis, on the other hand, is unplanned cell death caused by injury, toxins, or other negative outside factors; this causes inflammation and disrupts the body’s balance of things. There are stressors that speed up cell turnover. The study looked at photoreceptors in the retina and were able to demonstrate cellular recovery, even in late stages of apoptosis, recovery not breakdown. When certain stressors were reduced, by working with the mitochondria, there was recovery of the photoreceptor cells. How? Mitophagy, the mitochondria’s own process of programmed breaking down and then repurposing the recycled components for new ones. This mitochondrial repair helps to reverse the sequence of apoptosis for the photoreceptors. Mitochondria, how cool. How is this helpful for our eyes? Conditions like retinitis pigmentosa or macular degeneration directly involve the photoreceptors and may be slowed or reversed by helping the mitochondria. So, let’s take care of those mitochondria. There is some evidence for nutritional support for the mitochondrial system. The nutrient, Urolithin A (UA), which is a compound made in our gut from fiber found in pomegranates, berries, and nuts is the only clinically proven substance known to trigger mitophagy, made in the gut no less. Vitamin B3 is critical for mitochondria function, however vitamin B3 based supplements are still to be clinically tested for their support of cell recovery. Nutrients Coenzyme Q10 and L-carnitine are known to help the mitochondria generate energy, and interestingly, infrared light therapy has also been shown to benefit mitochondrial function. Again, food for thought. The gut and its function needs a lot of research. How do probiotics and nutrient precursors affect eye tissues? It is so interesting that the gut can be a factor in eye health. Maybe adding Urolithin A as a supplement is wise, along with the antioxidants in Lutein and Zeaxanthin we use to combat photoreceptor degeneration. Will keep you posted on any new developments.  The good doctor
By Dr. Mark Germain April 16, 2026
The good doctor focuses in on visual processing. Why do we miss things that are right in front of our eyes?
By Dr. Mark Germain April 10, 2026
The good doctor discusses the Artemis II mission, space travels affects on the eyes, and "the dark side of the moon"
By Dr. Mark Germain April 3, 2026
The good doctor discusses exciting new and emerging options to treat nystagmus.
By Dr. Mark Germain March 27, 2026
The good doctor reflects on The Country of the Blind, a book by Andrew Leland which gives insight into the experience of vision loss.
More Posts